Prognostic Value of Baseline Echocardiographic Parameters in Heart Failure With Improved vs Nonrecovered Ejection Fraction

Ejection fraction (EF) is often used as a prognostic indicator and for classifying heart failure (HF) patients. This study evaluates the association of echocardiographic parameters with HF with improved EF (HFimpEF). This single-centre study retrospectively included patients with HF with reduced EF...

Full description

Saved in:
Bibliographic Details
Published in:CJC open (Online) Vol. 5; no. 12; pp. 859 - 869
Main Authors: Prana Jagannatha, Gusti Ngurah, Suastika, Luh Oliva Saraswati, Kosasih, Anastasya Maria, de Liyis, Bryan Gervais, Yusrika, Mirani Ulfa, Kamardi, Stanly, Adrian, Jonathan, Pradnyana, I Wayan Agus Surya, Alamsyah, Alif Hakim, Cardia, Yosep Made Pius, Darmawan, Rizky, Rumangu, Anastasia Victoria, Pertiwi, Putu Febry Krisna
Format: Journal Article
Language:English
Published: United States Elsevier 01-12-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ejection fraction (EF) is often used as a prognostic indicator and for classifying heart failure (HF) patients. This study evaluates the association of echocardiographic parameters with HF with improved EF (HFimpEF). This single-centre study retrospectively included patients with HF with reduced EF (HFrEF) from a cohort of admitted patients over 2018-2020, who were then followed up prospectively until 2023. The control group was categorized as patients with non-recovered HFrEF, and the population group was categorized as patients with HFimpEF. A total of 176 patients with HFrEF were included in the study. Non-ischemic etiology was found to be the most prevalent cause of HFimpEF. The baseline echocardiography examination revealed that the HFimpEF group exhibited significantly higher values for tricuspid annular plane systolic excursion (TAPSE; < 0.001) and inferior vena cava diameter ( < 0.001). The non-recovered HFrEF group demonstrated higher baseline left atrial volume index (LAVi) values ( < 0.001). In multivariate analysis, a higher value of TAPSE (odds ratio 3.071;  = 0.008) and a lower value of LAVi (odds ratio 2.034;  = 0.008) were independent echocardiography variables associated with HFimpEF. After a mean follow-up duration of 32.5 ± 9.1 months, the HFimpEF group had higher survival from rehospitalization due to worsening HF and lower all-cause mortality (log rank < 0.001 and  = 0.005, respectively). Higher TAPSE and lower LAVi in baseline were associated with the transition from HFrEF to HFimpEF. The HFimpEF group had better survival compared to those with non-recovered HFrEF.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2589-790X
2589-790X
DOI:10.1016/j.cjco.2023.08.006